TY - JOUR T1 - Sofosbuvir/velpatasvir for 12 vs 6 weeks for the treatment of recently acquired hepatitis C infection JF - J Hepatol Y1 - 2021 A1 - Matthews, GV A1 - Bhagani, S A1 - Van der Valk, M A1 - et, al VL - S0168-8278 SP - 00336-6 IS - 21 ER -